返回 Agenda
Session 5 Track B: Building an Effective and Compliant Product Communication Strategy for Payors, Formulary Committees, and Similar Entities
Session Chair(s)
Sheetal Patel, PharmD
Vice President, Specialty Compliance
Johnson & Johnson, United States
With the advent of real world evidence and other continued evidence generation strategies of a product, building an effective and compliant product communication strategy is valuable to help payors, formulary committees, and other similar entities determine budgets and needs of their covered lives. This session will outline the current regulatory framework that allows the opportunity to communicate product information compliantly, explore the ability to effectively operationalize these efforts within an organization, and discuss future impact through regulatory reform of product communication to payors, formulary committees, and similar entities.
Learning Objective : At the conclusion of this session, participants should be able to: - Describe the current regulatory framework that governs communication with Payors, Formulary Committees, and Similar Entities
- Discuss opportunities and tools to operationalize the draft guidance
- Review the impact regulatory reform on product communication
Speaker(s)
Operationalizing an Effective and Compliant Product Communication Strategy
Amy Van Sant, PharmD, MBA
Inizio Engage, United States
President, Medical Affairs
Legal Framework and Regulatory Outlook
Katlin McKelvie Backfield, JD
Backfield PLLC, United States
Principal